Lv1
12 积分 2023-01-10 加入
Developability Assessment During the Selection of Novel Therapeutic Antibodies
2个月前
已完结
Predictive Screening Tools Used in High-Concentration Protein Formulation Development
2个月前
已完结
The Evolution of Commercial Antibody Formulations
2个月前
已完结
High-Throughput Screening for Colloidal Stability of Peptide Formulations Using Dynamic and Static Light Scattering
2个月前
已完结
Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
2个月前
已完结
Personalized Multi‐Epitope Nanovaccine Unlocks B Cell‐Mediated Multiple Pathways of Antitumor Immunity
4个月前
已完结
The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligand therapy in metastatic castration‐resistant prostate cancer: Turkish Oncology Group multicenter study
5个月前
已完结
Phase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer
5个月前
已完结
Resistance to second-generation androgen receptor antagonists in prostate cancer
5个月前
已完结
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
5个月前
已完结
皖公网安备34019202002308
